Genesis Capital back in clinical research with Crux Biolabs deal
It has cut a deal to take a controlling stake in the business, and existing owner Leading Technology Group will retain a minority position.
Source: afr.com
📰 Nucleus Network News
Page 3 - Nucleus Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nucleus Network. Real-time updates on events, politics, business and more.
Blackstone chews on Zambrero as strategic review awaits
It’s burritos all round in Blackstone’s private equity unit, as the group’s team runs the numbers on Australian born-and-bred fast food chain Zambrero.
United States New Zealand United Kingdom Australian Capital Territory Guzmany Gomez Magellan Financial Group
Source: afr.com
Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug
Irvine, CA, May 05, 2022 -- Odyssey Health, Inc. , f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, today announced positive results... | May 5, 2022
United States Michael Redmond Philip Ryan Odyssey Health Inc Odyssey Group International Inc Nucleus Networks
Source: marketscreener.com
A Guide to Preclinical and CMC Requirements for Conducting Clinical Trials in Australia, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) April 11, 2022 -- Sponsors are increasingly interested in conducting early phase clinical trials in Australia. This is because of
New Zealand Jason Lickliter Jon Fairweather Human Research Ethics Committee Honeycomb Worldwide Inc Nucleus Network
Source: prweb.com
Monash University poised to leverage proximity to Moderna's mRNA facility
Melbourne already has the researchers and the expertise in running drug trials ready to work with the pharma multinational.
Source: afr.com
NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED
IRVINE, CA, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the...
United States Jacob Vanlandingham Brett Favre Philip Ryan Principal Investigator At Nucleus Network Traumatic Brain Injury Mission
Source: globenewswire.com
NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION
IRVINE, CA, Feb. 11, 2022 -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. today announced the continued enrollment of its first in kind human clinical trial of its proprietary... | February 11, 2022
United States Jacob Vanlandingham Brett Favre Philip Ryan Centers For Disease Principal Investigator At Nucleus Network
Source: marketscreener.com
Blackstone Tees Up $11 Billion in Fresh Capital for Asia Deals
(Bloomberg) — Blackstone Inc. has amassed $11 billion to buy companies in Asia after raising its second private-equity fund for the region, nearly tripling its…
Source: financialpost.com
Quadrant buys a slice of clinical trials biz Southern Star Research
Quadrant Private Equity is the latest to join the dealmaking frenzy for clinical trials outfits.
Source: afr.com
Blackstone buys Crescent Capital's Nucleus Network
Global investment manager Blackstone has agreed terms to acquire clinical trials provider Nucleus Network from Australian private equity firm Crescent Capital.
Source: afr.com